ncRNA name
MALAT1
Specific or universal ncRNAs
Universal ncRNAs
Class
Long noncoding RNA
Biomarker
No
Biomarker application
Upstream regulatory factors
Not available
Downstream target
Not available
Cancer name
Non-Small Cell Lung Cancer
Cancer site
Lung
Treatment type
Chemotherapy
Drug
Cisplatin
Impact of wild-type ncRNA on chemotherapy resistance
Impact of knockdown of ncRNA on chemotherapy resistance
Impact of overexpression of ncRNA on chemotherapy resistance
Up
ncRNA differential expression in
cancer
patients vs. healthy people
Not available
Number of patients
Not available
Male patients
Not available
Female patients
Not available
Age range and number
Not available
PMID
Description
Knockdown of MALAT1 reversed cisplatin resistance in A549rCDDP cells.
Tissue resource
non-small cell lung cancer tissue samples
human non-small cell lung cancer cell lines A549
human non-small cell lung cancer cell lines H1299
Experiment
qRT-PCR,Western blot,Luciferase reporter assay
Institute
Shouguang People's Hospital
American Type Culture Collection
Country
China
USA
Continent
Asia
North American